Dec 15, 2025 08:01AM
Dec 15, 2025 08:00AM
Nov 12, 2025 04:05PM
Oct 3, 2025 04:10AM
Sep 26, 2025 04:23AM
Sep 11, 2025 04:05PM
Aug 12, 2025 04:18AM Quince Therapeutics Inc. (QNCX) PT Lowered to $8 at Citizens JMP
Aug 11, 2025 04:05PM
Jul 16, 2025 08:00AM
Jul 16, 2025 08:00AM
Jun 25, 2025 04:05PM
Jun 18, 2025 04:05PM
Jun 12, 2025 05:15PM
Jun 12, 2025 05:15PM Quince Therapeutics Announces Pricing of Up to $22 Million Private Placement of Securities
Jun 3, 2025 04:05PM
May 13, 2025 08:00AM
Mar 24, 2025 04:05PM
Feb 7, 2025 08:00AM
Feb 4, 2025 04:06PM
Feb 4, 2025 04:05PM
Jan 27, 2025 08:00AM Quince Therapeutics Announces Frontiers in Neurology Publication of Long-Term Safety of EryDex in Pediatric Patients with Ataxia-Telangiectasia
Nov 13, 2024 04:05PM
Nov 12, 2024 04:05PM
Nov 12, 2024 04:05PM
Nov 11, 2024 04:05PM
Nov 11, 2024 04:05PM
Aug 15, 2024 07:01AM
Aug 15, 2024 07:00AM Quince Therapeutics Announces The Lancet Neurology Publication of Phase 3 ATTeST Clinical Trial Data Evaluating EryDex for the Treatment of Ataxia-Telangiectasia (A-T)
Aug 13, 2024 04:05PM
Jun 25, 2024 07:00AM
Jun 3, 2024 07:00AM
Jun 3, 2024 07:00AM
May 13, 2024 07:00AM
Apr 1, 2024 07:00AM
Feb 15, 2024 07:03AM Quince Therapeutics (QNCX) Appoints Rajiv Patni to its Board
Feb 15, 2024 07:00AM
Oct 23, 2023 07:00AM
Sep 28, 2023 04:05PM
Sep 28, 2023 04:05PM
Jul 24, 2023 07:04AM
Jul 24, 2023 07:00AM
Jan 30, 2023 04:05PM Quince Therapeutics Provides Pipeline Update and Business Outlook for 2023
Sep 16, 2022 08:03AM
Sep 16, 2022 08:00AM
Aug 1, 2022 08:13AM
Aug 1, 2022 08:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All